Key points are not available for this paper at this time.
Design
Editorial
Editorial discussing a patient-level meta-analysis on baroreflex activation therapy in patients with heart failure with reduced ejection fraction.
This article refers to ‘Baroreflex activation therapy with the Barostim TM device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials’ by A.J.S. Coats et al. , published in this issue on pages 1 665– 1 673.
No takes yet. Share an insight, caveat, or question.
Gentile et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: